Drug: Gefitinib | Class: EGFR TKI | Brand: Iressa 250mg (AstraZeneca); Geftinat 250 (Natco India) | Indication: Non-small cell lung cancer (NSCLC) with EGFR exon 19 deletions or exon 21 L858R mutations | Dose: 250mg once daily orally
Gefitinib is used for non-small cell lung cancer (nsclc) with egfr exon 19 deletions or exon 21 l858r mutations. FDA-approved; IPASS trial: superior progression-free survival vs chemotherapy in EGFR-mutated NSCLC;. Prescription and monitoring required.
Gefitinib contains Gefitinib, a egfr tki for non-small cell lung cancer (nsclc) with egfr exon 19 deletions or exon 21 l858r mutations. FDA-approved; IPASS trial: superior progression-free survival vs chemotherapy in EGFR-mutated NSCLC; ESMO first-line for EGFR+ NSCLC.
| Attribute | Details |
|---|---|
| Generic Name | Gefitinib |
| Drug Class | EGFR TKI |
| Brand Reference | Iressa 250mg (AstraZeneca); Geftinat 250 (Natco India) |
| Indication | Non-small cell lung cancer (NSCLC) with EGFR exon 19 deletions or exon 21 L858R mutations |
| Standard Dose | 250mg once daily orally. Take with or without food. Continue until disease progression or unacceptable toxicity |
| Form | Tablet |
| Route | Oral |
| Prescription | Yes |
| Evidence | FDA-approved; IPASS trial: superior progression-free survival vs chemotherapy in EGFR-mutated NSCLC; ESMO first-line for EGFR+ NSCLC |
Reversibly inhibits EGFR tyrosine kinase blocking tumour cell proliferation.
Common serious effects include immunosuppression, opportunistic infections, and organ-specific toxicity depending on the agent. Regular monitoring is mandatory.
Regular blood tests including CBC, LFTs, and disease-specific markers are required. Frequency depends on dose and duration. Your prescriber will establish a monitoring schedule before and during treatment.
Yes
Duration depends on the indication — cancer treatments are protocol-defined; RA DMARDs may be lifelong if effective; osteoporosis treatment is reviewed at 3–5 years.
Most anti-cancer and immunosuppressive medications are contraindicated or require specialist risk assessment in pregnancy.
Store at 15–30°C away from sunlight and moisture. Keep out of reach of children.
Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.
Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.
All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.